000179445 001__ 179445
000179445 005__ 20240229145544.0
000179445 0247_ $$2doi$$a10.1177/17562872221087660
000179445 0247_ $$2ISSN$$a1756-2872
000179445 0247_ $$2ISSN$$a1756-2880
000179445 0247_ $$2altmetric$$aaltmetric:125759318
000179445 0247_ $$2pmid$$apmid:35356753
000179445 037__ $$aDKFZ-2022-00678
000179445 082__ $$a610
000179445 1001_ $$00000-0002-5069-3752$$aGrunewald, Camilla M.$$b0
000179445 245__ $$aCognitive function in patients undergoing cystectomy for bladder cancer – results from a prospective observational study
000179445 260__ $$aThousand Oaks, Calif.$$bSage$$c2022
000179445 3367_ $$2DRIVER$$aarticle
000179445 3367_ $$2DataCite$$aOutput Types/Journal article
000179445 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1649407402_19060
000179445 3367_ $$2BibTeX$$aARTICLE
000179445 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000179445 3367_ $$00$$2EndNote$$aJournal Article
000179445 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000179445 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000179445 7001_ $$aFeldmeier, Vera$$b1
000179445 7001_ $$aSupprian, Tillmann$$b2
000179445 7001_ $$0P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aAlbers, Peter$$b3$$udkfz
000179445 7001_ $$aGiessing, Markus$$b4
000179445 7001_ $$00000-0001-6929-8691$$aNiegisch, Günter$$b5
000179445 773__ $$0PERI:(DE-600)2492591-3$$a10.1177/17562872221087660$$gVol. 14, p. 175628722210876 -$$p175628722210876 -$$tTherapeutic advances in urology$$v14$$x1756-2872$$y2022
000179445 909CO $$ooai:inrepo02.dkfz.de:179445$$pVDB
000179445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000179445 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000179445 9141_ $$y2022
000179445 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ$$d2021-02-02
000179445 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000179445 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000179445 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-02-02
000179445 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-02-02
000179445 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-02-02
000179445 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2022-11-08$$wger
000179445 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-08
000179445 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-08
000179445 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-07-20T10:46:39Z
000179445 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-07-20T10:46:39Z
000179445 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-07-20T10:46:39Z
000179445 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-08
000179445 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-08
000179445 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-08
000179445 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bTHER ADV UROL : 2021$$d2022-11-08
000179445 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-08
000179445 9201_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x0
000179445 980__ $$ajournal
000179445 980__ $$aVDB
000179445 980__ $$aI:(DE-He78)C130-20160331
000179445 980__ $$aUNRESTRICTED